Ali Maruf

Mr. Ali Maruf

The Silesian University of Technology, Gliwice, Śląskie, Poland
orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2021 in Theranostics
Verified
Journal Article
Open access
YWYi Wang
Yi Wang
KZKang Zhang
Kang Zhang
TLTianhan Li
Tianhan Li
Ali MarufAli Maruf
Ali Maruf
XQXian Qin
Xian Qin
GWGuixue Wang
Guixue Wang
Atherosclerosis (AS), the underlying cause of most cardiovascular events, is one of the most common causes of human morbidity and mortality worldwide due to the lack of an efficient strategy for targeted therapy. In this work, we aimed to develop an ideal biomimetic nanoparticle for targeted AS therapy.

3 April 2019 in Advanced Healthcare Materials
Verified
Journal Article
Closed access
PDF file
Ali MarufAli Maruf
Ali Maruf
YWYi Wang
Yi Wang
TYTieyin Yin
Tieyin Yin
JHJunli Huang
Junli Huang
NWNan Wang
Nan Wang
GWGuixue Wang
Guixue Wang

21 June 2021 in Regenerative Biomaterials
Verified
Journal Article
Open access
PDF file
DTDan Tang
Dan Tang
YWYi Wang
Yi Wang
AWAndy Wijaya
Andy Wijaya
BLBoyan Liu
Boyan Liu
Ali MarufAli Maruf
Ali Maruf
GWGuixue Wang
Guixue Wang
The development of nanomedicines provides new opportunities for the treatment of atherosclerosis (AS) due to their great advantages such as the improved drug solubility, enhanced bioavailability and reduced side effects. Despite these advantages, nanomedicines are still facing some challenges. The problems remain in the short circulation life, lack of specific targeting and poor drug release controllability. In order to overcome the shortages of conventional nanomedicines, the combination of biomimetic strategy with smart nanoagents has been proposed. In light with the high reactive oxygen species (ROS) level in AS microenvironment and the fact that macrophages play a critical role in the pathogenesis of AS, we fabricated ROS-responsive biomimetic nanoparticles (NPs), which camouflaged macrophage membrane (MM) on ROS-responsive NPs loaded with rapamycin (RNPs) for potential application in AS therapy. The resulting ROS-responsive biomimetic NPs (MM/RNPs) exhibited favorable hydrodynamic size with negative surface charge, retained the functional proteins from MM, and showed ROS-responsive drug release. Because of the biomimetic camouflaging on surface, MM/RNPs could effectively escape from macrophages uptake and target to inflammatory endothelial cells. Meanwhile, MM/RNPs could inhibit the proliferation of macrophages and smooth muscle cells in vitro. Furthermore, the MM-coated NPs were found to be nontoxic in both cytotoxicity assay and in vivo toxicity evaluation. Consequently, these results demonstrated that MM/RNPs could be a potential candidate of drug delivery system for safe and effective anti-AS applications.

17 November 2021 in Journal of Nanobiotechnology
Verified
Journal Article
Open access
PDF file
BLBoyan Liu
Boyan Liu
Wenhua YanWenhua Yan
Wenhua Yan
LLLi Luo
Li Luo
SWShuai Wu
Shuai Wu
YWYi Wang
Yi Wang
GWGuixue Wang
Guixue Wang
Background: Intimal hyperplasia caused by vascular injury is an important pathological process of many vascular diseases, especially occlusive vascular disease. In recent years, Nano-drug delivery system has attracted a wide attention as a novel treatment strategy, but there are still some challenges such as high clearance rate and insufficient targeting. Results: In this study, we report a biomimetic ROS-responsive MM@PCM/RAP nanoparticle coated with macrophage membrane. The macrophage membrane with the innate “homing” capacity can superiorly regulate the recruitment of MM@PCM/RAP to inflammatory lesion to enhance target efficacy, and can also disguise MM@PCM/RAP nanoparticle as the autologous cell to avoid clearance by the immune system. In addition, MM@PCM/RAP can effectively improve the solubility of rapamycin and respond to the high concentration level of ROS accumulated in pathological lesion for controlling local cargo release, thereby increasing drug availability and reducing toxic side effects. Conclusions: Our findings validate that the rational design, biomimetic nanoparticles MM@PCM/RAP, can effectively inhibit the pathological process of intimal injury with excellent biocompatibility. Graphical

27 August 2018 in Bioconjugate Chemistry
Verified
Journal Article
Closed access
LLLi Luo
Li Luo
WWWei Wu
Wei Wu
Da SunDa Sun
Da Sun
HDHan-Bin Dai
Han-Bin Dai
YWYi Wang
Yi Wang
GWGuixue Wang
Guixue Wang

11 September 2020 in Journal of Materials Chemistry B
Verified
Journal Article
Closed access
PDF file
AGAlidha Gafur
Alidha Gafur
GSGerry Yusuf Sukamdani
Gerry Yusuf Sukamdani
NKNatalia Kristi
Natalia Kristi
Ali MarufAli Maruf
Ali Maruf
JXJing Xu
Jing Xu
ZYzhiyi ye
zhiyi ye
Bacterial biofilms caused by antibiotic resistance are a severe cause of infection threatening human health nowadays. The primary causes of this emerging threat are poor penetration of conventional antibiotics and the growing number of varied strains of resistant bacteria. Recently, bulk phytochemical oils have been widely explored for their potential as antibacterial agents. However, due to their poor solubility, low stability, and highly volatile properties, essential oils are not effective for in vitro and in vivo antibacterial applications and require further preparation. In this review, we discuss the recent progress and strategies to overcome the drawbacks of bulk phytochemical oils using nano-delivery, as well as the current challenges and future outlook of these nano-delivery systems against bacterial resistance.